A controlled, Randomised, Parallel, Multicentre Study to Assess Safety and Tolerabillity of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and other Thromboemboelic Complications. Associated with Atrial Fibrillatio
- Conditions
- Prevention of stroke and other thromboembolic omplications associated with Artrial Fibrillation.
- Registration Number
- EUCTR2004-000359-41-DK
- Lead Sponsor
- AstraZeneca AB
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 270
Inclusion Criteria
Are the trial subjects under 18?
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method